We developed another antigen recall assay in which the entire pp65 protein was processed and presented as heterogeneous pMHCs on HLA-A*0201+ B7-H3+ MDA-MB-231 breast cancer cells (MDA-MB-231-pp65). This evidence concerns the gene CD276 and breast carcinoma.